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Abstract
Background: Genetic analysis of a viral infection helps in following its spread in a given population, in tracking the routes of
infection and, where applicable, in vaccine design. Additionally, sequence analysis of the viral genome provides information
about patterns of genetic divergence that may have occurred during viral evolution.
Objective: In this study we have analyzed the subtypes of Human Immunodeficiency Virus -1 (HIV-1) circulating in a diverse
sample population of Nairobi, Kenya.
Methodology: 69 blood samples were collected from a diverse subject population attending the Aga Khan University
Hospital in Nairobi, Kenya. Total DNA was extracted from peripheral blood mononuclear cells (PBMCs), and used in a
Polymerase Chain Reaction (PCR) to amplify the HIV gag gene. The PCR amplimers were partially sequenced, and alignment
and phylogenetic analysis of these sequences was performed using the Los Alamos HIV Database.
Results: Blood samples from 69 HIV-1 infected subjects from varying ethnic backgrounds were analyzed. Sequence
alignment and phylogenetic analysis showed 39 isolates to be subtype A, 13 subtype D, 7 subtype C, 3 subtype AD and
CRF01_AE, 2 subtype G and 1 subtype AC and 1 AG. Deeper phylogenetic analysis revealed HIV subtype A sequences to be
highly divergent as compared to subtypes D and C.
Conclusion: Our analysis indicates that HIV-1 subtypes in the Nairobi province of Kenya are dominated by a genetically
diverse clade A. Additionally, the prevalence of highly divergent, complex subtypes, intersubtypes, and the recombinant
forms indicates viral mixing in Kenyan population, possibly as a result of dual infections.
Citation: Khoja S, Ojwang P, Khan S, Okinda N, Harania R, et al. (2008) Genetic Analysis of HIV-1 Subtypes in Nairobi, Kenya. PLoS ONE 3(9): e3191. doi:10.1371/
journal.pone.0003191
Editor: Jean K. Carr, Institute of Human Virology, United States of America
Received May 23, 2008; Accepted August 18, 2008; Published September 11, 2008
Copyright:  2008 Khoja et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was partly funded by the University Research Council, Aga Khan University, Karachi, the Higher Education Commission, Pakistan, grant 20-
775. The experimental work was performed in the Juma Research Laboratory, Aga Khan University Hospital, Karachi, Pakistan.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: syed.ali@aku.edu
Introduction
Human Immunodeficiency Virus (HIV) has several perplexing
attributes that distinguish it from other viruses. Important
determinants of the pathogenicity of this virus are its genetic
heterogeneity, which results mainly from the error-prone reverse-
transcriptase activity during viral replication (introducing an
average of one error per genome per replication cycle, the rapid
turn over of HIV-1 in vivo, recombination (which occurs at a rate of
about 2% per kilobase per replication cycle), and selective immune
pressure by the host [1–5].
HIV has been primarily classified on the basis of geographical
distribution and animal source of human infection into two types,
HIV-1 and HIV-2. Both of these types can be transmitted through
sexual contact and blood, as well as from mother to child, and are
capable of causing AIDS. The propensity of the virus towards
genetic diversity leads to rapid emergence of new types and
subtypes that evolve further into subtypes, recombinant forms and
quasispecies that are specific to infected groups and communities
[6–11]. Exhibition of tremendous genetic variation in HIV-1 due
to high mutation rates and recombination [12] has led to
classification of the virus into three distantly related groups; Main
group (M), Outlier group (O) and non-M-non-O group (N). The
M group that dominates the AIDS pandemic has been subdivided
into at least 12 distinct lineages, designated as subtypes and sub-
subtypes (A1, A2, B, C, D, F1, F2, G, H, J, K and L) and almost 33
circulating recombinant forms (CRF) [13–15]. Viral epidemiolog-
ical studies therefore provide opportunities to monitor the global
spread of HIV, tracking routes of infection and analyzing patterns
of virus’ genetic divergence [9].
Earlier studies have demonstrated that HIV-1 subtypes are not
randomly distributed among the globe and show distinct
geographical distribution [16,17]: Subtypes A and D are
predominant in Africa; subtype B in USA, Europe, Australia,
Thailand and Brazil; subtype C in South Africa, Ethiopia and
India; F in some regions of Central Africa and Eastern Europe and
CRF01_AE in southeast Asia [4,18–21]. With increase in the
prevalence of HIV, geographic distribution of subtypes has
diversified to a large extent. The greatest genetic variation in
HIV-1 has been found in regions where the HIV epidemic is
oldest such as the regions of sub-Saharan Africa where most of the
HIV-1 subtypes and many of the CRFs have been identified [22].
Kenya is one of the many countries of sub Saharan Africa region
where HIV pandemic has had an overwhelming effect. Estimates
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suggest that by the end of the year 2005, 1.5 million people of
Kenya were found to be HIV infected. In the same year, about
140,000 adults and children were estimated to have died from
AIDS [23]. Epidemiological Studies have indicated that majority
cases of HIV in Kenya belong to subtype A [24]. Although HIV-1
subtype A is dominant in Kenya there is an increasing prevalence
of other subtypes and recombinant viruses as well. For instance
CRF10 strain was first identified in western Kenya [25].
Epidemiological studies in Kenya have also reported increased
prevalence in subtype C and D [26].
There is no recent published data regarding HIV subtypes in
the general population of Nairobi, one of the main cities of Kenya.
Few studies were carried out to track the HIV-1 subtypes in
Nairobi but these studies are relatively outdated, have dealt with
limited sample size [26,27], or have targeted specific high risk
groups [28]. In the present study, we investigate the prevalence of
circulating HIV-1 subtypes in a sample size that is larger and more
diverse than the ones studied previously.
Materials and Methods
Study subjects
Ethical approval for this study was obtained from the Ethical
Research Council, Aga Khan University. For the study, HIV-
infected residents of Nairobi were recruited at the Aga Khan
Hospital, Nairobi, Kenya. Informed consent was obtained from all
participants along with the data on gender, age, ethnic
background, occupation, and marital status. HIV-1 status of these
subjects was previously known to be positive based on their HIV-1
antibody test. All subjects who gave consent were recruited into
the study, and their blood samples obtained during the year 2007.
Extraction of genomic DNA
3–4 ml of whole blood was collected from each subject.
Extraction of DNA was carried out as described previously [29].
Briefly, to 0.5 ml of peripheral blood mononuclear cells (PBMCs),
0.9 ml of 16RBC lysing solution (0.32 M Sucrose, 1% Triton X-
100, 5 mM MgCl2.6H2O, 12 mM Tris- HCl, pH 7.6) was added
and centrifuged at 13,000 rpm for 1 min. After discarding the
supernatant the pellet was re-extracted with 0.9 ml RBC lysing
solution. After centrifugation at 13,000 rpm, the pellet was washed
with 1 ml water. To the pellet, 20 ml of 20% SDS, 80 ml
Proteinase K buffer (0.375 M NaCl, 0.12 M EDTA, pH 8.0) and
40 ml of 10 mg/ml Proteinase K was added to the solution which
was then incubated at 56uC for 1 hour. Subsequently, 200 ml of
6 M NaCl was added to the suspension and then centrifuged at
13,000 rpm for 5 min. Supernatant was then transferred to a fresh
tube and added with 400 ml of isopropanol. DNA was then
pelleted by centrifugation at 13,000 rpm for 5 min. The DNA
pellet was washed with 70% ethanol, air-dried, re-suspended in
100 ml of water, and stored at 220uC.
b-globin PCR
To ascertain the quantity and quality of the extracted DNA, b-
globin PCR was carried out using the previously described [30]
primers PC03 (59-ACACAACTGTGTTCACTAGC-39) and
PC04 (59-CAACTTCATCCACGTTCACC-39). The final 25 ml
PCR mixture contained 5 ml samples, 16PCR buffer (56Green
GoTaqH Flexi Buffer, pH 8.5), 1 mM MgCl2, 200 mM dNTPs,
0.2 pmol of each primer and 0.2 U of Taq polymerase.
Thermocycle was: denaturation at 94uC for 5 min, followed by
40 cycles of denaturation at 94uC for 30 sec, annealing at 51uC for
30 sec and extension at 72uC for 30 sec, with a final extension of
at 72uC for 5 min.
Nested PCR for Gag Gene
PCR amplification of complete gag of HIV-1 was performed with
two sets of primers in a two-step nested PCR strategy. The primers
used in the first round of PCR were GOPF (59 CTCTCGACG-
CAGGACTCGGCTTGC-39, nt 683–706, HXB2) and GOPR (59-
CCAATTCCCCCTATCATTTTTGG-39, nt 2382–2404). For
the second round of amplification, primers GIPF (59- GAGGCTA-
GAAGGAGAGAGATGGG-39, nt 772–794, HXB2) and GIPR
(59-TTATTGTGACGAGGGGTCGTTGCC-39, nt 2269–2292)
were used.
The reaction mixture of 25 ml for both first and second round
PCR contained 16 PCR buffer (56Green GoTaqH Flexi Buffer,
pH 8.5), 2 mM MgCl2, 400 mM dNTPs and 0.3 U of Taq
Polymerase. The first round of PCR was performed with 0.48 pmol
of primers GOPF and GOPR. Thermocycle was: denaturation at
95uC for 5 min, followed by 35 cycles of denaturation at 95uC for
1 min, annealing at 58uC for 1 min and extension at 72uC for
1 min, with a final extension of at 72uC for 15 min.
1 ml of the first-round PCR product along with 0.48 pmol of the
primers GIPF and GIPR was used for the second-round PCR.
Thermocycle was: denaturation at 95uC for 5 min, followed by 35
cycles of denaturation at 95uC for 1 min, annealing at 60uC for
1 min and extension at 72uC for 1 min, with a final extension of at
72uC for 15 min. The amplified products were electrophoresed on
1.2% agarose gel, stained by ethidium bromide and visualized
under ultraviolet light.
Sequencing and Phylogenetic Analysis
Nested PCR products of gag gene were partially sequenced from
Macrogen Inc, Korea, using the primer GSP1 (59- CCATCAAT-
GAGGAAGCTGC-39, nt 1400–1418, HXB2). For subtyping and
further analysis, the nucleotide sequence spanning the p24 and p7
region of gag gene, nt 1577–2040, HXB2 [31] (comprising 460–
470 bp), was aligned with sequences from the Los Alamos HIV
sequence database. This was accomplished by using the HIV
BLAST Search (http://www.hiv.lanl.gov/). The samples were
assigned subtypes based on the closest homology found with the
subtype references in the Los Alamos database.
Using the same sequence, alignments were obtained by the
Clustal X program (1.83) [32]. After alignment the positions where
gaps occurred were stripped and minor manual adjustments were
made using MacClade [33]. From these alignments, phylogenetic
relationships were determined by using neighbor-joining method
with the help of PAUP* [34]. Pairwise genetic distances were
calculated with Kimura’s two parameter method [35] SimPlot
Version 3.5.1 was used for the analysis of recombinant subtypes[36]
. In order to establish geographic relationship between our and
previously reported strains, reference gag sequences from different
countries were selected from the Los Alamos HIV sequence
database and sequence alignment and phylogenetic analysis
performed. All of the sequences were analyzed for GRA
hypermutation using the consensus sequence for the appropriate
subtype by the Los AlamosHypermut Program (http://www.hiv.lanl.
gov/content/sequence/HYPERMUT/hypermut.html).
Results
Subject Profile
Samples collected in the year 2007, from 69 HIV-infected
subjects who consented to the study, were analyzed. Of these
subjects, 32 (46.37%) were males and 37 (53.63%) were females
(Table 1). Their ages ranged between 16 and 58 years (Table 1).
Recruited subjects had varying ethnic backgrounds with majority
being from Luo and Kikuyu communities followed by Kamba
HIV-1 Subtypes Kenya
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(Table 1). Distribution via occupation revealed a mixed picture:
persons involved in business numbered 10 (14.49%), technicians
10 (14.49%), clerks 6 (8.69%) and the rest constituting others
(Table 1). Distribution of risk groups was as follows: 76.81% had
history of unprotected sex, 15.94% had history of blood
transfusion whereas 4.34% had other risk factors (Table 1).
Subtyping and Phylogenetic Analysis
69 samples were successfully amplified for the gag gene in a
nested PCR, followed by sequencing. Generated sequences
(approximately covering 460–470 bp of p24 and p7 region of gag
gene, nt 1577–2040, HXB2) were then used for sequence
alignment using Clustal X and to construct the phylogenetic trees
using neighbor-joining method with PAUP*. Alignment of
sequences with reference sequences from Los Alamos database
and Phylogenetic analysis revealed that 39 (56.52%) of the 69
HIV-1 subtypes were A, 13 (18.84%) were subtype D, 7 (10.14%)
were subtype C and 2 (2.89%) were subtype G. Simplot analysis
revealed a few recombinant types in our study samples: 3 (4.34%)
being AD, 1 (1.44%) AC, 1 (1.44%) AG and 3 (4.34%)
CRF01_AE (Table 2, Fig. 1).
Phylogenetic Analysis for Geographic Relationship
For the three most represented subtypes in our study, namely, A,
D and C, deeper phylogenetic analysis was performed to explore
their geographic origin (Fig. 2A, B, C). Our sample subtype A
sequences clustered with sequences from varied geographical
regions represented by Uganda, Kenya, Sweden, Rwanda, South
Africa, Australia, India, China and Democratic Republic of the
Congo (Fig. 2A). These results indicate a significant diversity among
our subtype A sequences, possibly indicating an older HIV-1
infection in the Nairobi population. Conversely, Phylogenetic
analysis of subtype D sequences revealed a relatively lesser degree
of diversity (Fig. 2B). Sequences of 10 out of 12 strains for subtype D
clustered together, and with a reference sequence from Uganda
indicating a strong phylogenetic relationship and lesser genetic
divergence compared to subtype A sequences. Two out of twelve
subtype D sequences clustered independently with reference
sequences from Kenya. Lastly, subtype C sequences, in a manner
similar to our subtype D sequences, clutered closely together, and
with African countries (Fig. 2C). Four out of seven subtype C
sequences clustered closely with reference sequence from Ethiopia
while three sequences clustered with references from South Africa
and Botswana. One of the sequence, 26KE, representing subtype A,
was found to be hypermutated by the Hypermut Program at Los
Alamos Database (http://www.hiv.lanl.gov/content/sequence/
HYPERMUT/hypermut.html).
Discussion
In the present study we document the genetic diversity of HIV-1
strains in the general population of Nairobi, Kenya, by sequence
subtyping and phylogenetic analysis of gag region.
Subtype Distribution Profile
HIV-1 subtype Awas found to be the predominant type circulating
in the Nairobi population followed by subtypes D, C and G. These
findings suggest a consistent and continual spread of subtype A in
Nairobi (Table 2). The data presented here illustrate a heterogeneous
epidemic which is consistent with the previous epidemiological studies
in Kenya [24,27,37–41]. Homology of Kenyan subtype A samples
with multiple countries indicates that the origin of subtype A infection
in these countries may be from Kenya.
We have also identified recombinants AD, AC, AG and
CRF01_AE, which carry recombined subtype A genomic
sequences. Occurrence of these mixed subtypes and CRFs
indicates that subtype A is not only predominantly in circulation
in the Kenyan population but with time, it is slowly evolving and
Table 1. Distribution of study subjects on the basis of
gender, age, occupation, ethnicity and risk factors.
Characteristics Subcategory
Distribution of
Subjects
Gender Male 32 (46.37%)
Female 37 (53.63%)
Age Groups 11–20 2 (2.89%)
21–30 4 (5.79%)
31–40 34 (49.27%)
41–50 23 (33.33%)
51–60 6 (8.70%)
Occupation Business 10 (14.50%)
Technicians 10 (14.50%)
Clerks 6 (8.69%)
Drivers 5 (7.24%)
House wives 5 (7.24%)
Students and Teachers 4 (5.80%)
Others 29 (42.03%)
Ethnicity Luo 16 (23.18%)
Kikuyu 16 (23.18%)
Kamba 13 (18.84%)
Luhya 8 (11.59%)
Kalenjin 3 (4.34%)
Unknown 4 (5.80%)
Others 9 (13.04%)
Risk Factors Unprotected Sex 53 (76.81%)
Blood Transfusion &
Unprotected Sex
11 (15.94%)
Blood Transfusion 1 (1.44%)
Polygamous 1 (1.44%)
Unknown 3 (4.34%)
doi:10.1371/journal.pone.0003191.t001
Table 2. Distribution of HIV-1 subtypes in the studied
population.
Subtypes Number of Subjects
A 39 (56.52%)
D 13 (18.84%)
C 7 (10.14%)
G 2 (2.89%)
AD 3 (4.34%)
AC 1 (1.44%)
AG 1 (1.44%)
CRF01_AE 3 (4.34%)
doi:10.1371/journal.pone.0003191.t002
HIV-1 Subtypes Kenya
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diverging into new HIV strains. These recombinant forms might
have developed from recombination between parental subtype
strains within dually infected patients or through transmission of
already recombined strains to the subjects studied. With any of the
above possibilities it is evident that dual infections are common in
this population.
Figure 1. Phylogenetic analysis of HIV gag gene (p24-p7) sequences (nt 1577–2040, HXB2) from HIV infected Nairobi residents. This
tree (neighbor-joining) was created by aligning the selected sequences with reference sequences from Los Alamos database shown in bold). The
sequence F1.FR.96.MP411 was selected as the out group.
doi:10.1371/journal.pone.0003191.g001
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HIV-1 subtype distribution according to gender and age
Previous reports have suggested that HIV in Kenya is more
prevalent in women than in men [23], in our study as well, of the
recruited HIV seropositive subjects, majority was of females (37
women and 32 men). In female subjects the prevalent HIV-1
subtype was A (48.64%). The prevalence of subtype D (21.62%)
and C (13.51%) in women was found to be higher as compared to
men, which were, respectively, 15.62% and 6.25%.
Analysis of the patient profiles revealed that most of the study
subjects belonged to age group 31–50 years. Moreover, phyloge-
netic analysis of the samples from these age groups indicated the
prevalence of subtype G, intersubtype AD, AC and AG within the
age group of 31–40, whereas the prevalence of CRF01_AE was
found to be higher in the age group of 41–50 (66.67%) (Table 1).
HIV-1 subtype distribution according to Ethnicity
In our HIV seropositive study group, Luo and Kikuyu,
comprising 16 subjects each, were the most represented groups,
followed by Kamba (13 subjects) (Table 1). In the Luo group,
subtype A, D and its intersubtype AD were discovered while
subtype C was found to be surprisingly absent. Interestingly, all
subtypes discovered in this study were represented in the Kikuyu
group. These ethnic groups exhibit distinct cultural behavior and
practices which may play a crucial role in the transmission of HIV
within and from these groups. Distribution of various ethnicities in
Kenya is in the order: Kikuyu (22%), Luhya (14%), Luo (13%),
Kalenjin (12%), Kamba (11%). In our HIV positive subjects,
however, the order of predominance was: Luo/Kikuyu, Kamba,
Luhya, and Kalenjin. A high occurrence of HIV in Luo and
Kikuyu groups may have a connection with cultural and social
practices. Traditional male circumcision, which in certain trials
has been shown to be protective against HIV[42], is, for instance,
not practiced in the Luo ethnicity [43]. Polygamy and wife
inheritance, on the other hand, is common in the Luo community
[44], which may also play a role in increased transmission of HIV
and confinement of specific subtypes within this group. Finally,
CRF01_AE was found to be more prevalent in the ethnic group
Kamba (66.67%) compared to any other ethnic group. This was
an interesting observation since prevalence of CR01_AE,
previously reported in Central African Republic countries, Chad,
Congo, and Egypt, has not been noted in the East African region
(www.hiv.lanl.gov). Kamba ethnicity is distributed in the east-
central and coastal Kenya. Prevalence of CR01_AE in this tribe
may be attributed to their interaction with countries of Central
African Republic through trade and travel.
Phylogenetic relationship of Kenya subtypes with other
countries
Phylogenetically, most of the HIV-1 subtypes in our study have
shown their closest homology and association with African
countries such as Kenya, Uganda, South Africa, Ethiopia,
Rwanda, Botswana and Democratic Republic of Congo. These
geographic associations suggest that the bulk of HIV-1 infection in
Nairobi is likely to be a result of direct transmission of the virus
within these countries possibly via travelers across borders. Certain
viral strains bearing subtype A demonstrated closer homology to
Figure 2. Neighbor-Joining Phylogenetic trees of the three most represented subtypes, A (Fig. 2A), D (Fig. 2B) and C (Fig. 2C),
depicting geographical associations of the studied sample group with other global regions. Reference Sequences from Los Alamaos
Database have been indicated in bold. Out groups selected for Fig. 2A, B, and C were, respectively, A.EE.02.EST2002 394, NL.x.M12020, and
IL.98.98IS002.
doi:10.1371/journal.pone.0003191.g002
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strains from India, Australia and Sweden which may indicate
spread of these strains from or to Kenya. Closer relationship of our
subtype D and C, but not A, sequences with African subtypes may
indicate a propensity of transmission of these subtypes for specific
genetic backdrops.
Conclusion
Among the sub-Saharan African countries, Kenya has one of
the highest prevalence rates of HIV-1 infection [45]. HIV
infection among adults in urban areas, such as Nairobi, is almost
twice (10%) as high as in rural areas (5–6%). Studies previously
conducted in Nairobi have targeted particular high-risk groups
[28] and/or have relied on a limited number of samples [46].
Moreover, most of these studies date a few years back,
necessitating an update on general as well as molecular
epidemiology data [28,46]. Increasing variation among HIV
subtypes may have implications on HIV prevention and treatment
programmes. At this stage few vaccine trials in Kenya are
underway or are presently in the planning stage [47,48] and there
is a need to monitor the current extent of HIV-1 subtype
divergence in the infected population in different parts of the
country.
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